Related Experiment Video
Updated: Jun 21, 2026

A Doxorubicin-induced Cardiomyopathy Model in Adult Zebrafish
Published on: June 7, 2018
Capecitabine-induced cardiotoxicity: when to suspect? How to manage? A case report
Andrea Farina1, Cristina Malafronte, Maria Antonia Valsecchi
1Cardiology Division, Cardiovascular Department, A. Manzoni Hospital, Lecco, Italy. a.farina@ospedale.lecco.it
Abstract:
We present a case of capecitabine-induced cardiac toxicity manifested by chest pain, ST-segment elevation and ventricular tachycardia. Symptoms and ECG alterations were completely reversible after withdrawal of the drug. Coronary angiography demonstrated the absence of epicardial coronary spasm. We suggest cardiac monitoring with ECG Holter and effort ECG during the first days of drug administration. Prompt evaluation of chest pain in this setting is of paramount importance.
Related Concept Videos
Cardiomyopathy VI: Nursing Management
Cardiomyopathy III: Hypertrophic Cardiomyopathy
Drug Toxicity: Risk factors
Cardiomyopathy II: Dilated Cardiomyopathy
Cardiomyopathy IV: Restrictive Cardiomyopathy
Cardiomyopathy V: Interprofessional Care